Across TCGA pan-cancer cohorts, RPL31P11 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RPL31P11 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPL31P11 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RPL31P11 expression acts as an unfavorable survival marker.

COAD and SKCM are the cancer types where RPL31P11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.056	0.871	<.001	48	view →
SKCM	OS	Median	All	0.329	0.780	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL31P11 tumor-vs-normal RNA expression · all RPL31P11 data types